Works by Tsuburaya, Akira

Results: 86
    1
    2
    3
    4
    5
    6
    7

    A study of second-line irinotecan plus cisplatin vs. irinotecan alone in platinum-naïve patients with early relapse of gastric cancer refractory to adjuvant S-1 monotherapy: exploratory subgroup analysis of the randomized phase III TRICS trial.

    Published in:
    2019
    By:
    • Nishikawa, Kazuhiro;
    • Murotani, Kenta;
    • Fujitani, Kazumasa;
    • Inagaki, Hitoshi;
    • Akamaru, Yusuke;
    • Tokunaga, Shinya;
    • Takagi, Masakazu;
    • Tamura, Shigeyuki;
    • Sugimoto, Naotoshi;
    • Shigematsu, Tadashi;
    • Yoshikawa, Takaki;
    • Ishiguro, Tohru;
    • Nakamura, Masato;
    • Hasegawa, Hiroko;
    • Morita, Satoshi;
    • Miyashita, Yumi;
    • Tsuburaya, Akira;
    • Sakamoto, Junichi;
    • Tsujinaka, Toshimasa
    Publication type:
    journal article
    8
    9
    10

    A phase I study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1071, doi. 10.1007/s00280-009-0963-3
    By:
    • Yoshikawa, Takaki;
    • Tsuburaya, Akira;
    • Hirabayashi, Naoki;
    • Yoshida, Kazuhiro;
    • Nagata, Naoki;
    • Kodera, Yasuhiro;
    • Takahashi, Naoto;
    • Oba, Koji;
    • Kimura, Masayuki;
    • Ishikura, Satoshi;
    • Miyashita, Yumi;
    • Sakamoto, Junichi
    Publication type:
    Article
    11
    12
    13
    14
    15
    16

    The efficacy of gastrectomy for large gastric cancer.

    Published in:
    International Journal of Clinical Oncology, 2006, v. 11, n. 1, p. 44, doi. 10.1007/s10147-005-0535-4
    By:
    • Kobayashi, Osamu;
    • Tsuburaya, Akira;
    • Yoshikawa, Takaki;
    • Osaragi, Tomohiko;
    • Murakami, Hitoshi;
    • Yoshida, Tatsuya;
    • Sairenji, Motonori
    Publication type:
    Article
    17
    18
    19
    20
    21

    Surgical advantages of reduced-port laparoscopic gastrectomy in gastric cancer.

    Published in:
    2016
    By:
    • Kunisaki, Chikara;
    • Makino, Hirochika;
    • Yamaguchi, Naotaka;
    • Izumisawa, Yusuke;
    • Miyamato, Hiroshi;
    • Sato, Kei;
    • Hayashi, Tsutomu;
    • Sugano, Nobuhiro;
    • Suzuki, Yoshihiro;
    • Ota, Mitsuyoshi;
    • Tsuburaya, Akira;
    • Kimura, Jun;
    • Takagawa, Ryo;
    • Kosaka, Takashi;
    • Ono, Hidetaka;
    • Akiyama, Hirotoshi;
    • Endo, Itaru;
    • Ono, Hidetaka Andrew
    Publication type:
    journal article
    22
    23
    24
    25
    26

    A Comparison of Multimodality Treatment: Two and Four Courses of Neoadjuvant Chemotherapy Using S-1/CDDP or S-1/CDDP/Docetaxel Followed by Surgery and S-1 Adjuvant Chemotherapy for Macroscopically Resectable Serosa-positive Gastric Cancer: A ...

    Published in:
    Japanese Journal of Clinical Oncology, 2012, v. 42, n. 1, p. 74, doi. 10.1093/jjco/hyr166
    By:
    • Yoshikawa, Takaki;
    • Taguri, Masataka;
    • Sakuramoto, Shinichi;
    • Kunisaki, Chikara;
    • Fukunaga, Tetsu;
    • Ito, Seiji;
    • Cho, Haruhiko;
    • Tanabe, Kazuaki;
    • Nishikawa, Kazuhiro;
    • Matsui, Takanori;
    • Morita, Satoshi;
    • Tsuburaya, Akira
    Publication type:
    Article
    27
    28
    29
    30
    31

    A Randomized Phase III trial of Post-operative Adjuvant Oral Fluoropyrimidine versus Sequential Paclitaxel/Oral Fluoropyrimidine; and UFT versus S1 for T3/T4 Gastric Carcinoma: The Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial.

    Published in:
    Japanese Journal of Clinical Oncology, 2005, v. 35, n. 11, p. 672, doi. 10.1093/jjco/hyi179
    By:
    • Tsuburaya, Akira;
    • Sakamoto, Junichi;
    • Morita, Satoshi;
    • Kodera, Yasuhiro;
    • Kobayashi, Michiya;
    • Miyashita, Yumi;
    • Macdonald, John S.
    Publication type:
    Article
    32
    33
    34

    Differences in efficacy of biweekly irinotecan plus cisplatin versus irinotecan alone in second-line treatment of advanced gastric cancer with or without prior gastrectomy.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 320, doi. 10.1007/s10147-024-02661-6
    By:
    • Nishikawa, Kazuhiro;
    • Koizumi, Wasaburo;
    • Tsuburaya, Akira;
    • Suzuki, Motoko;
    • Morita, Satoshi;
    • Fujitani, Kazumasa;
    • Akamaru, Yusuke;
    • Shimada, Ken;
    • Hosaka, Hisashi;
    • Nishimura, Ken;
    • Yoshikawa, Takaki;
    • Tsujinaka, Toshimasa;
    • Sakamoto, Junichi
    Publication type:
    Article
    35

    Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 11, p. 1501, doi. 10.1007/s10147-023-02402-1
    By:
    • Nishikawa, Kazuhiro;
    • Kawakami, Hisato;
    • Shimokawa, Toshio;
    • Fujitani, Kazumasa;
    • Tamura, Shigeyuki;
    • Endo, Shunji;
    • Kobayashi, Michiya;
    • Kawada, Junji;
    • Kurokawa, Yukinori;
    • Tsuburaya, Akira;
    • Yoshikawa, Takaki;
    • Sakamoto, Junichi;
    • Satoh, Taroh
    Publication type:
    Article
    36
    37
    38

    Meta-analysis of two randomized phase III trials (TCOG GI-0801 and ECRIN TRICS) of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer.

    Published in:
    Gastric Cancer, 2020, v. 23, n. 1, p. 160, doi. 10.1007/s10120-019-00990-4
    By:
    • Nishikawa, Kazuhiro;
    • Koizumi, Wasaburo;
    • Tsuburaya, Akira;
    • Yamanaka, Takeharu;
    • Morita, Satoshi;
    • Fujitani, Kazumasa;
    • Akamaru, Yusuke;
    • Shimada, Ken;
    • Hosaka, Hisashi;
    • Nakayama, Norisuke;
    • Tsujinaka, Toshimasa;
    • Sakamoto, Junichi
    Publication type:
    Article
    39
    40

    A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial.

    Published in:
    Gastric Cancer, 2018, v. 21, n. 5, p. 811, doi. 10.1007/s10120-018-0815-0
    By:
    • Nishikawa, Kazuhiro;
    • Tsuburaya, Akira;
    • Yoshikawa, Takaki;
    • Takahashi, Masazumi;
    • Tanabe, Kazuaki;
    • Yamaguchi, Kensei;
    • Yoshino, Shigefumi;
    • Namikawa, Tsutomu;
    • Aoyama, Toru;
    • Rino, Yasushi;
    • Kawada, Junji;
    • Tsuji, Akihito;
    • Taira, Koichi;
    • Kimura, Yutaka;
    • Kodera, Yasuhiro;
    • Hirashima, Yoshinori;
    • Yabusaki, Hiroshi;
    • Hirabayashi, Naoki;
    • Fujitani, Kazumasa;
    • Miyashita, Yumi
    Publication type:
    Article
    41
    42
    43
    44

    High false-negative proportion of intraoperative histological examination as a serious problem for clinical application of sentinel node biopsy for early gastric cancer: final results of the Japan Clinical Oncology Group multicenter trial JCOG0302.

    Published in:
    Gastric Cancer, 2014, v. 17, n. 2, p. 316, doi. 10.1007/s10120-013-0285-3
    By:
    • Miyashiro, Isao;
    • Hiratsuka, Masahiro;
    • Sasako, Mitsuru;
    • Sano, Takeshi;
    • Mizusawa, Junki;
    • Nakamura, Kenichi;
    • Nashimoto, Atsushi;
    • Tsuburaya, Akira;
    • Fukushima, Norimasa
    Publication type:
    Article
    45
    46
    47
    48
    49

    Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: multi-institutional retrospective analysis.

    Published in:
    Gastric Cancer, 2012, v. 15, n. 3, p. 245, doi. 10.1007/s10120-011-0101-x
    By:
    • Shitara, Kohei;
    • Morita, Satoshi;
    • Fujitani, Kazumasa;
    • Kadowaki, Shigenori;
    • Takiguchi, Nobuhiro;
    • Hirabayashi, Naoki;
    • Takahashi, Masazumi;
    • Takagi, Masakazu;
    • Tokunaga, Yukihiko;
    • Fukushima, Ryoji;
    • Munakata, Yasuhiro;
    • Nishikawa, Kazuhiro;
    • Takagane, Akinori;
    • Tanaka, Takaho;
    • Sekishita, Yoshiaki;
    • Sakamoto, Junichi;
    • Tsuburaya, Akira
    Publication type:
    Article
    50